Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
EBS · against 1,336 other Healthcare companies
Ranked #275 of 1,337 · scores higher than 79% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 70–79, including EBS · Click a bar to see the companies
Mainly thanks to its free cash flow yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | EBS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -54.4% | 1.5% | 5% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 30.5% | 4.2% | 97% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 26.8% | -1.0% | 98% | 20% | |
| Book yieldHigher is better · 1,306 reported | 106.5% | 37.9% | 88% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 275 | 1.85T JPY (≈$12.5B) | 79 | 55 | |
| 275 | 11.2B EUR (≈$12.3B) | 79 | 63 | |
| 275 | 1.5B SGD (≈$1.1B) | 79 | 60 | |
| 275 | 905M CHF (≈$1.0B) | 79 | 75 | |
| 275 | 320M USD | 79 | 44 | |
| 275 | 1.7B EUR (≈$1.9B) | 79 | 58 | |
| 275 | 468M EUR (≈$514M) | 79 | 57 | |
| 275 | 418M USD | 79 | 74 | |
| 275 | 3.0B THB (≈$83M) | 79 | 52 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score